G erminal centers (GCs) are specialized areas of secondary lymphoid tissues in which B cells undergo antibody affinity maturation. The GC can be divided into a dark zone (DZ), characterized by extensive proliferation and somatic hypermutation, and a light zone (LZ), where B cells are less proliferative and make contacts with follicular dendritic cells and T cells. There, B cells are positively selected to survive and undergo further rounds of proliferation in the DZ 1,2 . Help provided by T cells promotes faster progression through the cell cycle, a greater number of cell divisions and increased frequency of somatic hypermutation, which results in increased antibody affinity maturation 3, 4 . Positive selection in the LZ results in the transient expression of the transcription factor c-MYC necessary for the progression of selected cells through the cell cycle 5,6 . c-MYC also induces the transcription of genes encoding products important for anabolic metabolism 3,7 . Moreover, activity of the metabolic checkpoint kinase complex mTORC1 is increased during positive selection and promotes the anabolic gene-expression program 8 . In addition to c-MYC, the transcription factors AP4, FOXO1 and BATF are important during the LZ-DZ transition of GC B cells 9-11 . Such findings highlight the existence in B cells of relays of transcription factors that are responsive to T cell help and promote B cell proliferation and mutation.
, presented as normalized read counts (from DESeq2 software for the analysis of differential gene expression on the basis of negative binomial distribution). NS, not significant (P > 0.1); *P < 0.05 and ***P < 0.001 (DESeq2; adjusted P values). b, Gating strategy for GC and non-GC B cells (left) (full gating strategy, Supplementary Fig. 1e ), and expression of PTBP1, PTBP2 and PTBP3 (middle and right) by the gated populations (key), analyzed by flow cytometry 7 d after immunization of mice with NP-KLH and presented as geometric mean fluorescence intensity (gMFI) for each antibody after subtraction of background staining with isotype-matched control antibodies ( Supplementary Fig. 1f ). Numbers adjacent to outlined areas (left) indicate percent cells in each gate. c, Flow-cytometry analysis of the expression of the costimulatory molecule CD86 and the chemokine receptor CXCR4 (left) by GFP-c-MYC + GC B cells (dots) and GFP-c-MYC -GC B cells (shading), and of the expression of PTBP1 and PTBP3 (middle and right) in GFP-c-MYC + and GFP-c-MYC -GC B cells (key) from Myc GFP/GFP mice 6 d after immunization with SRBCs. Each symbol represents an individual mRNAseq library (a) or mouse (b,c); bar tops indicate the mean. NS, not significant (P > 0.1); **P < 0.01 and ***P < 0.001 (two-tailed paired Student's t-test (b,c)). Data are representative of three independent experiments (b) or one experiment (c).
Articles
NATuRe IMMuNoLoGY hemocyanin (NP-KLH). 7 d later, the proportion and absolute number of GC B cells per spleen were lower (5.9-fold and 3.9-fold, respectively) in Cd79a Cre/+ Ptbp1 fl/fl (cKO) mice than in Cd79a +/+ Ptbp1 fl/fl (control) mice ( Fig. 2a,b ). The proportion of GC B cells with a DZ phenotype was lower in Ptbp1-deficient GC B cells than in Ptbp1-sufficient (control) GC B cells ( Fig. 2a,b) , despite efficient depletion of the protein in the cells ( Supplementary Fig. 3a ). In contrast, Cd79a Cre/+ Ptbp1 fl/+ mice immunized with NP-KLH showed GC B cell responses similar to those of Cd79a +/+ Ptbp1 fl/fl mice ( Supplementary Fig. 3b ,c). The same GC B cell defects were found in Cd79a Cre/+ Ptbp1 fl/fl (cKO) GC B cells from B6.SJL chimeras reconstituted with a 1:1 mixture of bone marrow cells from CD45.1 + B6.SJL mice and CD45.2 + Cd79a Cre/+ Ptbp1 fl/fl (cKO) mice ( Supplementary Fig. 3d,e ). Therefore, the defect in Ptbp1-deficient GC B cells was cell autonomous. These data indicated an indispensable role for the function of PTBP1 in GC B cells.
PTBP1 is necessary for antibody affinity maturation. Cd79a Cre/+ Ptbp1 fl/fl (cKO) mice produced lower amounts of highaffinity antibodies than did Cd79a +/+ Ptbp1 fl/fl (control) mice (Fig. 2c ).
In Cd79a +/+ Ptbp1 fl/fl (control) mice, the ratio of high-affinity antibodies to high-and low-affinity antibodies increased over time, but this ratio remained low in Cd79a Cre/+ Ptbp1 fl/fl (cKO) mice (Fig. 2d ). Antibodies from mice lacking Ptbp2 in B cells (Cd79a Cre/+ Ptbp2 fl/fl mice) showed no defect in affinity maturation relative to that of antibodies from Cd79a +/+ Ptbp2 fl/fl mice ( Supplementary Fig. 3f ,g). Cd79a Cre/+ Ptbp1 fl/fl (cKO) GC B cells had switched to immunoglobulin G1 (IgG1) in vivo at a greater frequency than had Cd79a +/+ Ptbp1 fl/fl (control) GC B cells ( Supplementary Fig. 3h ), which indicated the presence of functional activation-induced cytidine deaminase (AID) in Ptbp1-deficient GC B cells. Additionally, mutations were found at a similar frequency in the intronic region of the gene encoding heavy-chain joining region 4 in GC B cells sorted from Cd79a Cre/+ Ptbp1 fl/fl mice and those from Cd79a +/+ Ptbp1 fl/fl mice ( Supplementary Fig. 3i,j) . Thus, PTBP1 was necessary in B cells for optimal antibody affinity maturation, but this probably did not stem from diminished function of AID.
PTBP2 partially compensates for the loss of PTBP1 in GC B cells.
The expression of PTBP2 in Ptbp1-deficient GC B cells might compensate for the absence of PTBP1 in GC cells 31, 32 . To address this in the absence of confounding effects due to the deletion of genes during the bone marrow stages of B cell development, we intro- blood cells (SRBCs), the number and proportion of GC B cells was lower in AicdaTg-CrePtbp1 fl/fl (cKO) mice than in Ptbp1 fl/fl Ptbp2 fl/fl (control) mice, and the remaining GC B cells had the altered LZ-DZ phenotype seen in Cd79a Cre/+ Ptbp1 fl/fl mice ( Fig. 3a,b ). AicdaTg-CrePtbp1 +/+ Ptbp2 +/+ mice showed a number of LZ and DZ B cells similar to that of Ptbp1 fl/fl Ptbp2 fl/fl (control) mice ( Supplementary  Fig. 3k ). Thus, the function of PTBP1 in B cells was required subsequent to B cell activation and expression of AID.
Considerably fewer GC B cells were detected in AicdaTg-CrePtbp1 fl/fl Ptbp2 fl/fl (dcKO) mice than in Ptbp1 fl/fl Ptbp2 fl/fl (control) or AicdaTg-Cre Ptbp1 fl/fl (cKO) mice (Fig. 3a,b and Supplementary   Fig. 3k ). The residual AicdaTg-CrePtbp1 fl/fl Ptbp2 fl/fl (dcKO) GC B cells had the phenotype typical of LZ B cells ( Fig. 3a,b ), and they expressed PTBP3, had lower expression of PTBP1 than that of Ptbp1sufficient GC B cells (from Ptbp1 fl/fl Ptbp2 fl/fl mice) but expressed no PTBP2 ( Fig. 3c,d) . No NP-specific IgG1-antibody-secreting cells were detected in AicdaTg-Cre Ptbp1 fl/fl Ptbp2 fl/fl (dcKO) mice 21 d after immunization with NP-KLH (data not shown). Thus, PTBP2, but not PTBP3, partially compensated for the loss of PTBP1. PTBP1 regulates mRNA abundance and AS in GC B cells. We performed mRNA sequencing (mRNAseq) on LZ and DZ B cells 
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from Cd79a +/+ Ptbp1 fl/fl (control) mice and Cd79a Cre/+ Ptbp1 fl/fl (PTBP1-cKO) mice. In addition, we generated a transcriptomewide inventory of PTBP1-binding sites in mitogen-activated B cells using individual-nucleotide-resolution cross-linking and immunoprecipitation (iCLIP) (Supplementary Table 1 ). By combining mRNAseq with iCLIP of PTBP1, we were able to distinguish the direct effects of PTBP1 on the transcriptome from its indirect effects and, through the consideration of positional information, we were able to deduce the likely mechanism of action of PTBP1. Changes in mRNA abundance at the whole-gene level in control LZ B cells relative to those in control DZ B cells were consistent with published changes 33 and were conserved in Ptbp1-deficient GC B cells ( Fig. 4a , Supplementary Fig. 4a,b and Supplementary Table 2 ).
We found 998 genes with increased mRNA abundance and 980 genes with decreased mRNA abundance in PTBP1-cKO LZ GC B cells relative to their abundance in control LZ GC B cells, and 409 genes with increased mRNA abundance and 270 genes with decreased mRNA abundance in PTBP1-cKO DZ GC B cells relative to their abundance in control DZ GC B cells ( Fig. 4b and Supplementary Table 2 ). The changes in genes that were expressed differentially in LZ B cells and DZ B cells due to deletion of Ptbp1 showed a strong positive correlation ( Supplementary Fig. 4c ), which indicated that the absence of PTBP1 affected the same genes in LZ B cells that it affected in DZ B cells. PTBP1 can increase mRNA stability when bound to 3′ untranslated regions (UTRs) 19 
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NATuRe IMMuNoLoGY their 3′ UTRs was similar (~20%, Supplementary Fig. 4d ). Thus, binding of PTBP1 to 3′ UTRs did not seem to have a substantial 'preference' toward increasing mRNA stability or decreasing it in GC B cells. We used the rMATS computational tool (for the detection of differential AS) to determine inclusion-level differences between any two conditions for five different types of AS events ( Supplementary  Fig. 4e ,f). We identified 266 AS events that were more skipped in control LZ B cells than in control DZ B cells and 316 AS events that were more included in control LZ B cells than in control DZ B cells (all from 506 genes), with an inclusion-level difference greater than 10% ( Fig. 4c and Supplementary Table 3 ); this indicated extensive changes in AS in the transition between LZ and DZ. The changes in AS due to Ptbp1 deficiency were greater in both the magnitude of events and the number of events ( Fig. 4d , 856 AS events in LZ GC B cells and 960 AS events in DZ GC B cells) than the differences noted NS, not significant (P > 0.05); *P < 0.05 (unpaired two-tailed Student's t-test). e, Differential AS events (FDR < 0.05) with an inclusion-level difference greater than 10% due to Ptbp1 deletion in LZ GC B cells, assessed for genes in sets as in a (above plots); right margin, gene symbol, followed by the type of AS event (as in Fig. 4c ) and the rMATS identification number (Supplementary Table 3 ; genes bound by PTBP1 near the AS event, Supplementary Table 5 ). Data are from four independent experiments with four mRNAseq libraries per condition (a,b,e) or are representative of one experiment (c,d).
for control LZ GC B cells versus control DZ GC B cells ( Fig. 4c , 582 events). The 52% overlap of AS events that were different in control LZ B cells versus control DZ B cells and those affected by Ptbp1 deletion ( Supplementary Fig. 4g ) indicated that PTBP1 affected a substantial proportion of the AS events that differed in LZ B cells versus DZ B cells. 379 AS events were more skipped and 477 AS events were more included (in 670 genes) in PTBP1-cKO LZ B cells than in control LZ B cells ( Fig. 4d and Supplementary Table 3 ). 416 AS events were more skipped and 544 AS events were more included (in 747 genes) in PTBP1-cKO DZ B cells than in control DZ B cells ( Fig. 4d and Supplementary Table 3 ). The proportion of AS events directly regulated by PTBP1, inferred from the binding of PTBP1 in the vicinity of the event, varied depending on the type of AS event and ranged from ~50% in mutually exclusive exons to ~7% in alternative 3′ splice sites ( Supplementary Fig. 4h ). Among AS events more skipped or more included in PTBP1-cKO B cells than in control B cells, the proportion of events that were bound in their vicinity by PTBP1 in our PTBP1 iCLIP data was similar ( Supplementary Fig. 4h ), which indicated that PTBP1 both repressed AS and activated AS in GC B cells. The overlap between genes with different mRNA abundance and those with different AS due to deletion of Ptbp1 was 6% in the LZ and in 8% the DZ (Fig. 4e ). Similarly, there was a small overlap between genes with changes in abundance and AS in the comparison of Cd79a +/+ Ptbp1 fl/fl (control) LZ B cells versus control Cd79a +/+ Ptbp1 fl/fl (control) DZ B cells ( Fig. 4e ). Together our data identified PTBP1 as a post-transcriptional regulator in GC B cells, in which it controlled mRNA abundance and five different types of AS events.
PTBP1 is necessary for the c-MYC-dependent program induced after positive selection.
To determine if PTBP1 regulated changes in annotated gene-ontology (GO) pathways, we assessed genes with changes at the level of mRNA abundance or AS due to Ptbp1 deletion separately. Several GO terms relevant to the biology of GC B cells showed enrichment for genes with a difference in mRNA abundance due to deletion of Ptbp1 ( Supplementary Fig. 5 and Supplementary Table 4 ). No pathways showed enrichment (falsediscovery rate (FDR), < 0.1) when AS changes were analyzed ( Supplementary Table 4 ). Instead, individual genes of different pathways were regulated by PTBP1 at the level of AS.
Pathways involved in nucleotide biosynthesis and cell proliferation ( Supplementary Fig. 5a -c) showed enrichment for genes with differential mRNA abundance in LZ B cells and DZ B cells due to the lack of PTBP1. In LZ B cells, most of the differentially expressed genes within these pathways had decreased mRNA abundance ( Supplementary Fig. 5b ). LZ B cells showed enrichment for The Ras protein signaling pathway was also enrichment in LZ B cells with genes that had different mRNA abudance, but most of these genes had increased mRNA abundance due to the lack of PTBP1 ( Supplementary Fig. 5b ). Pathways linked to B cell differentiation, lymphocyte migration, cholesterol metabolism and the regulation of apoptosis in leukocytes ( Supplementary Fig. 5a ,c) showed enrichment for genes with different mRNA abundance in DZ B cells due to deletion of Ptbp1. Among the 243 genes with different mRNA abundance that belonged to the enriched pathways, we found that 64 were bound by PTBP1 in their 3′ UTR and only 10 had AS in the absence of PTBP1 ( Supplementary Fig. 5b,c) . Thus, PTBP1 directly regulated some of these genes but also had an indirect effect on the expression of genes in these pathways. We investigated further how the lack of PTBP1 affected the expression of genes that are part of the c-MYC hallmark 34 and also of genes induced in response to T cell help 3, 7 . In LZ B cells lacking PTBP1, there was a globally lower mRNA abundance of the genes induced after positive selection relative to the mRNA abundance of such genes in Cd79a +/+ Ptbp1 fl/fl (control) LZ B cells ( Fig. 5a ). 21% of the genes with lower mRNA abundance in LZ B cells due to deletion of Ptbp1 were part of the gene-expression program induced after positive selection ( Supplementary Fig. 6a and Supplementary Table 5 ). The abundance of Myc mRNA and its AS pattern were the same in Cd79a Cre/+ Ptbp1 fl/fl (cKO) LZ B cells and Cd79a +/+ Ptbp1 fl/fl (control) LZ B cells ( Fig. 5b and Supplementary Table 3 ). We recon- (Fig. 5c,d) . Furthermore, the abundance of Tfap4 mRNA, which encodes AP4 (Fig. 5b) , and the phosphorylation of ribosomal protein S6 at Ser240 and Ser244 ( Supplementary Fig. 6b Supplementary Fig. 6c -e and Supplementary Table 3 ). Thus GC B cells do not require PTBP1 for the sensing of T cell help or the induced expression of c-MYC. 28% of the mRNAs that were part of the c-MYC-dependent gene-expression program induced after positive selection and that were decreased in LZ B cells due to Ptbp1 deletion were bound by PTBP1 in their 3′ UTR ( Supplementary Fig. 6a and Supplementary  Table 5 ). This indicated a direct role for PTBP1 in stabilizing a fraction, but not all, of c-MYC-dependent transcripts. Moreover, 22 genes that were induced after positive selection showed differential AS (inclusion-level difference > 10%) in Ptbp1-deficient LZ B cells relative to their AS in Cd79a +/+ Ptbp1 fl/fl (control) LZ B cells ( Fig. 5e and Supplementary Fig. 6a ), and six of these were bound by PTBP1 near the AS event (Supplementary Table 5 ). Pkm (which encodes pyruvate kinase), Abcb1b (which encodes an ATP-binding-cassette transporter), Tspan33 (which encodes a tetraspanin protein), Phb2 (which encodes the repressor Bcap37) and Dkc1 (which encodes the dyskerin pseudouridine synthase DKC1) were the only genes with both decreased mRNA abundance and differential AS (inclusionlevel difference > 10%) due to the lack of PTBP1. Thus, PTBP1 regulated expression of the c-MYC-dependent gene-expression program both directly and indirectly in positively selected GC B cells by regulating mRNA abundance and AS.
PTBP1 regulates the proliferation of GC B cells.
We investigated whether PTBP1 was required for GC B cell proliferation by measuring DNA content and incorporation of the thymidine analog bromodeoxyuridine (BrdU) into GC B cells in vivo. The proportion of Cd79a Cre/+ Ptbp1 fl/fl (cKO) GC B cells in late S phase (BrdU + with high DNA content) was lower than that of Cd79a +/+ Ptbp1 fl/fl (control) GC B cells in late S phase, in mice immunized with NP-KLH ( Fig. 6a,b) . In contrast, the proportion of cells that were in early S phase (BrdU + with low DNA content) was similar among (Fig. 6a,b) .
The proportion of cells in late S phase was lower among both LZ B cells (in five of five experiments) and DZ B cells (in four of five experiments) from Cd79a
Cre/+ Ptbp1 fl/fl (cKO) mice than among those from Cd79a +/+ Ptbp1 fl/fl (control) mice ( Supplementary Fig. 7a ). We also observed a lower proportion of cells in late S phase among GC B cells from AicdaTg-CrePtbp1 fl/fl (cKO) mice than among those from AicdaTg-CrePtbp1 +/+ Ptbp2 +/+ or Ptbp1 fl/fl Ptbp2 fl/fl mice, after immunization with SRBCs ( Supplementary Fig.7b ). The proportion of GC B cells in late S phase was also lower among CD45.2 + Ptbp1-deficient cells than among CD45.2 + Ptbp1-sufficient cells from B6.SJL competitive chimeras reconstituted with a 1:1 mixture of bone marrow cells from CD45.1 + B6.SJL mice and CD45.2 + Cd79a Cre/+ Ptbp1 fl/fl (cKO) mice or from CD45.1 + B6.SJL mice and CD45.2 + Cd79a +/+ Ptbp1 fl/fl (control) mice and then immunized with NP-KLH ( Supplementary Fig. 7c ), which showed that this was a cellautonomous defect. In contrast to results obtained for GC B cells, the proportion of cells at different stages of the cell cycle was normal among the highly proliferative early-pre B cells of Cd79a Cre/+ Ptbp1 fl/fl (cKO) mice ( Supplementary Fig. 7d ). Thus, PTBP1 was not universally required in cells that were undergoing cell division but was necessary for the progression of GC B cells through late S phase. Closer analysis of the expression of genes encoding molecules important for progression through the cell cycle revealed that the expression of Ccnd2, Ccnd3 and Ccne2 was unaffected in Cd79a Cre/+ Ptbp1 fl/fl (cKO) GC B cells relative to such expression in Cd79a +/+ Ptbp1 fl/fl (control) GC B cells ( Supplementary Fig. 7e ), which suggested that the enrichment for proliferation and nucleotide-biosynthetic GO pathways did not arise from a failure to express early cell-cycle-progression factors. Impaired nucleotide synthesis could cause replication stress as cells progress through S phase and could cause cell death 35 . Flow cytometry using a fixable viability dye to detect non-viable cells showed a higher proportion of dead cells among Cd79a Cre/+ Ptbp1 fl/fl DZ GC B cells than among Cd79a +/+ Ptbp1 fl/fl DZ GC B cells (Fig. 6c,d) . In contrast, the proportion of dead cells among LZ B cells were similar for Ptbp1-deficient cells and Ptbp1-sufficient cells (Fig. 6c,d) . Thus, PTBP1 was necessary for progression through the S and G2-M phases of the cell cycle and promoted the survival of DZ cells.
PTBP1 controls AS of c-Myc-dependent genes that encode molecules important for proliferation.
Given the impaired proliferation of Ptbp1-deficient GC B cells, we looked for evidence of PTBP1-dependent AS isoforms among genes that were part of the c-MYC-dependent gene-expression program and encoded molecules important for proliferation. mRNA from the gene encoding thymidylate synthase (Tyms, a target of c-MYC; Fig. 5a ), which is necessary for de novo nucleotide synthesis, was 30-fold greater in abundance in GC B cells than in naive B cells and increased after positive selection in GC B cells (Fig. 7a) . Tyms mRNA was spliced differently in the absence of PTBP1 (Fig. 7b ). Deletion of Ptbp1 resulted in a complex AS pattern, with increased inclusion of exons and retained introns (yellow bins, Fig. 7b ) that generated transcript isoforms predicted to be degraded by NMD. We quantified the ratio of mRNAseq reads that mapped to segments generating transcripts predicted to be degraded by NMD ('NMD reads'; yellow bins, Fig. 7b ) to mRNAseq reads that mapped to the first three exons of Tyms, which encode the full-length (FL) protein ('FL reads'; blue bins, Fig. 7b ). The ratio of NMD reads to FL reads was reduced after positive selection in GC B cells (Fig. 7c) , which indicated an increase in protein-coding Tyms mRNA in positively selected GC B cells. The ratio of NMD reads to FL reads was higher in Ptbp1-deficient LZ and DZ B cells than in Ptbp1-sufficient LZ and DZ B cells (Fig. 7d ). The abundance of Tyms mRNA (at the whole-gene level) was reduced due to deletion of Ptbp1 in LZ B cells (Fig. 7e ). TYMS protein was decreased in abundance due to deletion Ptbp1 in LZ and DZ B cells (Fig. 7f ). Consistent with a direct role for PTBP1 in regulating those Tyms AS events, iCLIP analysis showed PTBP1 bound to the AS region of Tyms (Fig. 7b ). These data indicated that PTBP1 ensured increased expression of TYMS during positive selection by regulating AS of Tyms.
The pyruvate kinase PKM catalyzes the conversion of phosphoenolpyruvate to pyruvate in glycolysis and is also encoded by a target of c-MYC 28 that was spliced differentially due to deletion of Ptbp1 (Fig. 5e ). Pkm encodes two protein isoforms generated from mutually exclusive inclusion of exon 9 (PKM1) or exon 10 (PKM2). Whereas PKM1 exists only as a highly active tetrameric form, PKM2 interchanges among less-active monomeric and dimeric forms as well as a fully active tetramer in response to nutrient availability and energy demands 36 . B cells expressed Pkm2 almost exclusively, and Pkm2 was induced after positive selection in GC B cells, but Pkm1 was not (Fig. 8a) . In the absence of PTBP1, the inclusion level of exon 9 increased from 0.05 to 0.2 (Fig. 8b,c) . Immunoblot analysis of proteins from naive and mitogen-activated B cells in vitro revealed that PKM1 was hardly detected in Cd79a +/+ Ptbp1 fl/fl B cells but was readily detected in Cd79a Cre/+ Ptbp1 fl/fl (cKO) B cells (Fig. 8d ). This AS event has been shown to be regulated by PTBP1 in human cell lines to favor the production of PKM2 28, 31 . Our iCLIP data revealed binding of PTBP1 close to the intronic 3′ splice site of Pkm exon 9 in B cells (Fig. 8c ). Thus, PTBP1 promoted skipping of this exon in favor of the inclusion of exon 10 and suppression of Pkm1 mRNA in GC B cells (Fig. 8e ).
Expression of PKM1 has been shown to impair the proliferation of malignant cells and non-transformed fibroblasts, and the small molecule DASA-58 activates the tetramerization of PKM2 and inhibits the proliferation of transformed cells 36 . DASA-58 reduced the proliferation of mouse B cells in response to in vitro stimulation with antibody to the costimulatory receptor CD40 plus the cytokines IL-4 and IL-5 or stimulation with antibody to IgM plus IL-4 ( Fig. 8f,g) . These findings were consistent with the hypothesis that increased activity of pyruvate kinase, as would be expected after PKM1 expression, is detrimental for B cell proliferation.
Discussion
PTBP1 is either induced by and acts downstream of c-MYC or forms part of a previously unrecognized pathway that acts in parallel with c-MYC to drive GC B cell proliferation. We favor the former hypothesis, as there is evidence that PTBP1 is encoded by a c-MYCresponsive gene in other cell systems 28, 29 . A proliferation defect of Ptbp1-deficient embryonic stem cells and human CD4 + T cells with reduced levels of PTBP1 has been observed 30, 37, 38 , which indicates that PTBP1 is necessary for cell proliferation in other systems, although the basis for the reported effects is not clear. However, the requirement for PTBP1 in proliferation is not universal, as the proliferation of Ptbp1-deficient early pre-B cells was normal. This difference could reflect compensatory mechanisms or the distinct environment of the GC versus that of the bone marrow 39, 40 . PTBP1 controlled gene expression by regulating multiple processes in the biogenesis and fate of mRNA. The mRNA abundance or AS of 213 genes that were part of the c-MYC-dependent geneexpression program induced after positive selection was PTBP1 dependent, but there were additional direct and indirect targets of PTBP1 that were not part of the MYC-dependent program. Among those, we observed changes in the AS of Sema4d, Pdlim7, Pbrm1, Acly and Ikzf3. Changes in semaphorin 4d (CD100; encoded by Sema4d) could affect the migration of GC B cells through the LZ and DZ and interactions with T cells 41 . Changes in enigma (encoded by Pdlim7) could alter expression of the tumor suppressor p53 42 . Altered splicing of the gene encoding ATP citrate lyase (Acly) could have an effect on lipid biosynthesis 43 . Polybromo-1 (BAF180; encoded by Pbrm1) is part of the SWI-SNF-B (PBAF) chromatinremodeling complex and is a cofactor of c-MYC that might help propagate the c-MYC-induced gene-expression program 44 , and alterations in Aiolos (encoded by Ikzf3) might influence plasma cell formation 45 . Despite the potential for molecules encoded by these genes to have roles in GC B cell biology, most of the alternative isoforms found have not been studied before, to our knowledge. Elucidation of the functions of molecules encoded by these AS transcripts in GC B cell biology will require careful investigation.
Pkm and Tyms are but two examples of c-MYC-regulated genes that are subject to PTBP1-dependent AS. Inhibition of TYMS by 5-flurouracil blocks the proliferation of primary T cells 46 and B cells in vitro (data not shown). Splicing of the retained intron upstream of exon 2 from the full-length Tyms transcript is necessary for increased Tyms mRNA expression in cultured cells 47 . Reduced amounts of TYMS could be one limiting factor for the proliferation of positively selected GC B cells. Other events regulated by PTBP1 must also promote GC B cell proliferation, and our results indicate that the regulation of PKM activity is important for B cell proliferation. PTBP1, by regulating the AS of Pkm, might limit glycolytic flux and thereby contribute to biosynthetic pathways through the accumulation of glycolytic intermediates 36 . Consistent with that, PKM1 is growth inhibitory when it is expressed in cancer xenograft tumor models 36 , and B cell proliferation in vitro was inhibited by activators of PKM2.
Published studies have reported a function for PTBP2 in antibody class-switch recombination 48 . We did not detect PTBP2 expression in GC B cells unless Ptbp1 was deleted, and secretion of antigen-specific IgG1 was unaffected in mice with Ptbp2-deficient B cells. Therefore, it is unlikely that PTBP2 promotes class-switch recombination in GC B cells. Nonetheless, the increase in the frequency of IgG1 + GC B cells among Ptbp1-deficient GC B cells might indicate that, if expressed, PTBP2 might indeed promote antibody class-switch recombination.
There might be additional PTBP1-mediated post-transcriptional processes of importance to the GC reaction. Changes in APA analyzed with the DaPars tool found that deletion of Ptbp1 affected the APA of four genes in LZ B cells and seven genes in DZ B cells (data not shown), suggestive of a more limited role for PTBP1 in regulating APA in GC B cells than its roles controlling AS and mRNA abundance. However, full elucidation of the roles of PTBP1 in APA will require analysis of RNA-based next-generation sequencing libraries specifically targeted at capturing 3′ ends. In the present study, we were unable to measure the effect of PTBP1 on the tempo of translation, such as through internal-ribosomal-entry-site-mediated regulation, within GC B cells, and this must await improved techniques for measuring translational regulation in rare cell populations.
In summary, we observed that the regulation of gene expression in B cells by PTBP1 was necessary for GC B cell proliferation. At the cellular level, PTBP1 functioned in GC B cells to promote the rapid progression through the late S phase of the cell cycle. At the molecular level, we identified the role of PTBP1 in regulating the quantitative and qualitative changes in the transcriptome that were part of the c-MYC-dependent gene-expression program. Posttranscriptional regulation by PTBP1 acted in concert with transcription factors such as c-MYC to integrate anabolic metabolism and cell-cycle progression and to drive the production of highaffinity antibodies.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-017-0035-5.
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Methods
Mice. All mice were on a C57BL/6 background. For bone marrow chimera experiments, B6.SJL were used as recipients. Conditional-knockout mice used in this study derive from crossing the following transgenic strains: Ptbp1 fl/fl (Ptbp1 tm1Msol ) 30 , Ptbp2 fl/fl (Ptbp2 tm1.1Dblk ) 50 , Cd79a Cre (Cd79a tm1(Cre)Reth ) 51 and AicdaTg-Cre (Tg(Aicda-Cre)9 Mbu ) 52 as specified in the Results section. GFP-c-MYC (Myc tm1Slek ) reporter mice 53 and Rag2 −/− mice (Rag2 tm1Fwa ) 54 were also used in this study.
Rats. RT7b rats were used for the generation of monoclonal antibodies to PTBP3.
Immunization protocols and in vivo BrdU administration. All procedures performed were approved by the Babraham Institute's Animal Welfare and Experimentation Committee and the UK Home Office and are in compliance with all relevant ethical regulations. Mice immunized with alum-NP-KLH received 100 μg NP-KLH (Biosearch Technologies) intraperitoneally. Mice immunized with SRBCs received 2 × 10 8 SRBCs intraperitoneally. For in vivo BrdU incorporation experiments, mice received 2 mg BrdU intraperitoneally 1.5 h before they were culled. Bone marrow competitive chimeras were generated by reconstitution of lethally irradiated (500 rads, twice) B6.SJL mice with 3 × 10 6 bone marrow cells derived from B6.SJL mice at a 1:1 ratio with CD79a Cre/+ Ptbp1 fl/fl (cKO) or CD79a +/+ Ptbp1 fl/fl control bone marrow cells, administered intravenously. Rag2 −/− bone marrow chimeras were generated by reconstitution of sublethally irradiated (500 rads, once) Rag2 −/− mice with 3 × 10 6 bone marrow cells from Cd79a +/ Ptbp1 fl/fl Myc GFP/GFP or Cd79a Cre/+ Ptbp1 fl/fl Myc GFP/GFP mice, administered intravenously. Mice used in immunization experiments with different genotypes were sex and age matched. Whenever possible, littermates of the same sex but different genotypes were kept in the same cages to avoid confounding effects. Male and female mice were used in this study. Except in bone marrow-reconstitution experiments, immunizations were carried out on 8-to 14-week-old mice. Bone marrow competitive chimeras were immunized 15 weeks after reconstitution. Rag2 −/− bone marrow chimeras were immunized 13 weeks after reconstitution.
Flow cytometry. Single-cell suspensions were prepared from tissues by passing the tissues though cell strainers with 70 and 40 μm pore sizes. After Fc receptors (CD16/32) were blocked with the monoclonal rat antibody 2.4G2 (BioXcell), cells were stained with antibodies (Supplementary Table 6 ) in 1% FCS PBS at 4 °C. Cell viability was assessed by staining cells with the Fixable Viability Dye eFluor 780 dye from eBioscience. Unless otherwise stated, dead cells were always excluded from the analysis. For intracellular staining cells were fixed and permeabilized with the BD Cytofix/Cytoperm Fixation and Permeabilization Solution from BD Biosciences. Nuclear permeabilization was carried out with the Permeabilization Buffer Plus from BD Biosciences when cells were prepared from the spleen or by freezing fixed cells in FCS containing 10% DMSO at -80 °C when cells were isolated from the bone marrow. Intracellular staining was carried out by incubating permeabilized cells with combinations of antibodies (Supplementary Table 6 ) diluted in BD Perm/Wash Buffer. For some intracellular staining, such as for the detection of PTBP1, the incubation with antibodies was carried out for 4 h at room temperature. A Foxp3/Transcription Factor Staining Buffer Set from eBioscience was also occasionally used. Staining of BrdU and DNA was carried out using the FITC BrdU Flow Kit from BD Biosciences. Monoclonal antibodies to PTBP1, PTBP2 and PTBP3 were directly conjugated using Alexa Fluor 488, Alexa Fluor 647 or Pacific Blue Antibody Labeling Kits from ThermoFisher Scientific.
Detection of NP specific immunoglobulins. NP-specific antibodies of different affinities were detected as previously described 14 using two different conjugation ratios of NP to BSA. Detection of NP-specific antibodies with low and high affinity was done by coating ELISA plates with a ratio of at least 20 NP moieties per BSA molecule (NP20, Biosearch Technologies). Detection of NP-specific antibodies with only high affinity was performed by coating ELISA plates with a ratio of 2 NP moieties per BSA molecule. Endpoint titers were calculated from serial dilutions of serum samples.
Isolation of B cells and ex vivo stimulation.
B cells were isolated from spleens of mice after preparing a single-cell suspension by MACS negative depletion with a B cell isolation kit (Cat. # 130-090-862 from Miltenyi). When stimulated ex vivo, B cells were cultured in IMDM (Cat # 21980, ThermoFisher Scientific) with l-glutamine and 25 mM HEPES, supplemented with 10% heat-inactivated FCS, 50 μM β-mercaptoethanol, penicillin and streptomycin (GIBCO). Cells were stimulated with LPS (10 μg/ml 127:B0, Sigma); anti-CD40 (FGK4.2, 10 μg/ml, from BioXcell), IL-4 (10 ng/ml) and IL-5 (10 ng/ml) or anti-IgM (B7.6, 9 μg/ml, from Jackson ImmunoResearch) and IL-4 (10 ng/ml). In proliferation assays, B cells were labeled with CellTrace Violet (ThermoFisher) before culture. 1.5 × 10 5 B cells were added per well in 96-well plates. Cells were counted using counting beads analyzed by flow cytometry. In PKM stimulation experiments DASA-58 55 (MedChem Express, Cat. # HY-19330-1ml) was added to the cultures. The same amount of DMSO as the highest concentration of DASA-58 was added to the cultures as vehicle control. PTBP1 iCLIP. iCLIP reveals the site of direct binding of a RBP to RNA at singlenucleotide resolution. This is achieved first by the covalent binding of the RBP to its cognate RNA in intact cells by UV irradiation and second, through the truncation of cDNA synthesis when reverse polymerase encounters residual peptides derived from the RBP at the site of cross-linking to the RNA 56 . PTBP1 immunoprecipitation was carried out with monoclonal antibody CLONE 1 (ThermoFisher Scientific, Cat. # 32-4800) coupled to protein A/G magnetic beads (Pierce, Cat. #88802) and UV-cross-linked (150mJ/cm 2 ) cell extracts of primary B cells stimulated ex vivo for 48 h with LPS as described above. B cells were isolated from several C57BL/6 female mice and were pooled together before stimulation. 30 × 10 6 cells were used in each immunoprecipitation and were lysed in 50 mM Tris-HCL, pH7.4, 100 mM NaCl, 1% NP-40 and 0.1% SDS lysis buffer. Before immunoprecipitation of PTBP1, cell extracts were treated with Turbo DNAse (Ambion, #AM2239) and small amounts of RNAse I (1.5 to 3 units) from Ambion (Cat. # AM2294). Immunoprecipitates were separated by SDS-PAGE and RNA-protein complexes were transferred to a nitrocellulose membrane. Protein-RNA complexes were isolated from the nitrocellulose membrane after cutting only the areas (from ~75 to ~120 kDa) where PTBP1 was expected to be cross-linked to long RNAs. After protein digestion, RNA was isolated and cDNA was synthetized by reverse transcription. At this time bar-coded primers were used that allow the identification of cDNAs generated from the same RNA molecule (with a random unknown four-nucleotide barcode), which allows the discrimination of PCR duplicates, and then multiplexing of several samples together. Amplification of iCLIP cDNA libraries was done with 20-27 PCR cycles. We carried out five replicates. Multiplexed iCLIP cDNA libraries were sequenced on an Illumina HiSeq 2000 platform on a 50-bp single-ended mode. Negative controls (immunoprecipitation of PTBP1 from non-UV-cross-linked lysates and immunoprecipitation with a mouse IgG1 negative isotype-matched control antibody(MOPC-1, Sigma, Cat. # 015K4806) resulted in very little isolated RNA, from which no cDNA library could be generated.
Computational processing of iCLIP data. Identification of transcriptome-wide PTBP1 binding sites was done as previously described 56 . In brief, mapping of cDNAs to the mouse genome (mm10) was carried out with Bowtie, and those reads that mapped to the same location and had the same random four-nucleotide barcode were considered PCR duplicates and collapsed as a single cDNA molecule. A PTBP1-binding site (or X-link site) is the nucleotide before the first nucleotide of a mapped cDNA molecule. An FDR value, which determines the probability of a X-link site to appear by chance, was calculated (as described 56 ) for each X-link site. iCLIP is highly dependent on RNA abundance and therefore, is not an absolute measurement of RNA-protein interactions. For this reason we pooled the five replicates together before calculating FDRs for each X-link site.
Generation of mRNAseq libraries. LZ and DZ GC B cells were sorted by flow cytometry from CD79a Cre/+ Ptbp1 fl/fl or CD79a +/+ Ptbp1 fl/fl mice immunized with alum-NP-KLH 7 d before. Single-cell suspensions were prepared from spleens of immunized mice. Erythrocytes were lysed and GC B cells were enriched before sorting by flow cytometry by depletion of cells stained with biotinylated anti-IgD (11-26c.2a, Southern Biotech), anti-CD3e (145-2C11, eBioscience), anti-Gr1 (RB6-8C5, ThermoFisher) and anti-Ter119 (TER-119, eBioscience) by MACS. Four biological replicates were used per condition. In each biological replicate, GC B cell-enriched splenocytes from three to five mice of the same genotype and sex were pooled together before sorting by flow cytometry. LZ and DZ GC B cells were sorted from the same GC B cell-enriched samples. LZ and DZ GC B cells from CD79a +/+ Ptbp1 fl/fl and CD79a Cre/+ Ptbp1 fl/fl mice were sorted on the same day. Two biological replicates per condition were from female mice and two from male mice.
RNA was prepared using the RNeasy Micro Kit kit from Qiagen (Cat. #74004) from ~25,000 cells to ~200,000 cells. RNA quality was analyzed on a 2100 Bioanalyzer (Agilent). RNA integrity numbers ranged from 9.1 ng to 10. 2 ng of total RNA was used to generate cDNA from polyadenylated transcripts using the SMART-Seq v4 Ultra low input RNA kit from Clontech (Cat. #634888). cDNA quality was analyzed on a 2100 Bioanalyzer (Agilent). 0.5 ng cDNA were used to prepare the mRNAseq libraries with eight cycles of PCR using the Ultra Low library preparation kit v2 from Clontech (Cat. #634899). Compatible barcoded libraries were multiplexed and sequenced across three lanes on an Illumina HiSeq 2500 platform on a 100-bp paired-end mode.
Analysis of mRNAseq libraries generated in this study. Trimming of libraries was carried out with Trimgalore (v0.4.2) using default parameters. After that, reads were mapped to the mouse Mus_musculus.GRCm38 genome with Hisat2 57 using -p 7 -t-phred33-quals-no-mixed-no-discordant parameters and providing a known splice sites file generated from the Mus_musculus.GRCm38.70.gtf annotation. Counting of reads mapping to all exons of a particular gene was done with HTSeq 58 using the Mus_musculus.GRCm38.84.gtf annotation and default parameters. DESeq2 (v1.12.1) 59 was used to calculate differential RNA abundance between two conditions at the whole gene level by quantifying differences in RNA nature research | life sciences reporting summary 
Data exclusions
Describe any data exclusions. In Figure 1b , data from one mouse was excluded because the fluorescence intensity for the PTBP3 intracellular staining was 1.5-fold higher than the mean for both non-GC and GC B cells. The reason why this data point was excluded is because this was seen only once in one out three experiments.
In the experiment shown in Figure 3 one mouse had a expansion of non lymphoid cells. Data collected from this mouse was excluded.
In Supplementary Figure 3c data from two mice were excluded from the graphs showing absolute numbers because they had splenomegaly. Rarely, the fluorescence intensity of the BrdU staining in GC B cells was not sufficient to allow proper gating of cells in early/late S-phase. Data from mice where this occurred were excluded from the analysis. Occasionally control or conditional KO mice did not respond at all to the immunisation protocols. The data from these mice is not included in the figures.
Replication
Describe whether the experimental findings were reliably reproduced.
All replication experiments were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For experiments with mice, samples were randomly analyzed with out separating mice by genotype.
For mRNAseq experiments, four biological replicates were used per condition. In each biological replicate, GC B cell-enriched splenocytes from 3 to 5 animals of the same genotype and sex were pooled together before FACS sorting. LZ and DZ GC B cells were sorted from the same GC B cell enriched samples. LZ and DZ GC B cells from control CD79a+/+Ptbp1fl/fl and CD79acre/+Ptbp1fl/fl cKO mice were sorted on the same day. Two biological replicates per condition were from females and two from males.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
To analyze mRNAseq libraries the following software was used: Trimgalore (v0.4. Statistical analysis was carried out with Prism (versions 7 or 6), except for genome wide data which was carried out with the software listed above.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials 
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Novel anti-PTBP3 monoclonal antibodies are reported in this study and their validation by immunoblot of proteins derived from mouse primary B cells is shown in Supplementary Figure 2a .
Other antibodies also listed in Supplementary 10. Describe the software used to collect and analyze the ChIP-seq data.
Analysis of the iCLIP and software used to process the raw reads are described in Online Methods
